Axonova Medical

• Kritika Katiyar

  Director, research and development

• Harry Ledebur

Sources: reporter.nih.gov

• National Institute of Neurological Disorders and Stroke

  R44, Generation of Tissue Engineered Nerve Grafts from GalSafe Porcine Neurons, R44NS108869, $901K, 2018–2024, Aug 17, 2022

• National Institute of Neurological Disorders and Stroke

  R43, Development of Tissue Engineered Neuromuscular Interfaces from GalSafe Neurons., R43NS125892, $250K, 2022–2023, Jan 11, 2022

• National Institute of Neurological Disorders and Stroke

  R43, Generation of Tissue Engineered Nerve Grafts from GalSafe Porcine Neurons, R43NS108869, $225K, 2018–2020, Sep 21, 2018

Sources: reporter.nih.gov